Dental Equipment & Technology Q3 Earnings: Envista (NYSE:NVST) Simply the Best

Envista Holdings (NYSE:NVST) delivered the strongest Q3 performance among tracked dental equipment and technology stocks, beating analyst revenue estimates significantly and achieving the fastest revenue growth. Henry Schein (NYSE:HSIC) and Align Technology (NYSE:ALGN) also reported strong quarters, with their stocks rising after earnings. Dentsply Sirona (NYSE:XRAY), however, had the weakest performance with declining revenues and missed EPS guidance.

Original reporting
Published Jan 1, 2026, 11:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jan 1, 2026, 11:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Dental Equipment & Technology Q3 Earnings: Envista (NYSE:NVST) Simply the Best — source image
Decision brief

The 30-second read

$NVSTBullishMed
01

Why it matters

Positive earnings reports from key players have reinforced investor confidence, leading to bullish sentiment and potential short-term price gains.

02

Market read

The sector's strong Q3 earnings suggest a positive outlook, with potential benefits for related stocks and ETFs.

03

What to watch

Potential regulatory changes or supply chain disruptions could impact sector performance; macroeconomic factors such as interest rate hikes may affect valuations.

Timing: Immediate to short-term

Background

The dental equipment and technology sector demonstrated strong earnings in Q3, driven by increased demand and technological innovation.

Company-level read

Ticker impact

$NVSTBullishHigh confidence
Context

Primary focus due to strong Q3 earnings and bullish sentiment.

Expected impact

Moderate upward movement expected in NVST stock over the short to medium term.

Evidence & confidence

Strong earnings beat, positive sentiment, and sector momentum support bullish outlook; however, sector variability warrants caution.

$HSICBullishMedium confidence
Context

Secondary relevance due to positive earnings and bullish sentiment.

Expected impact

Potential modest increase in HSIC stock price.

Evidence & confidence

Strong earnings support positive outlook, but less pronounced than NVST.

$ALGNBullishMedium confidence
Context

Secondary relevance due to positive earnings and bullish sentiment.

Expected impact

Potential modest increase in ALGN stock price.

Evidence & confidence

Sector momentum supports positive outlook, but individual company factors may influence outcomes.

Market effects

Strength in dental equipment and technology sectors; potential spill-over into related healthcare sectors.

Primarily US-focused, given the US-based companies; limited immediate regional impact.

Moderate, as some companies operate internationally, but sector-specific.

Counterpoint

Sector rotation or profit-taking could lead to short-term declines; Dentsply Sirona's weak performance may signal underlying sector challenges.

Key entities

  • Envista Holdings

    A leading provider of dental equipment and technology.

  • Henry Schein

    A global distributor of healthcare products and services.

  • Align Technology

    A manufacturer of clear aligners and digital orthodontic solutions.

  • Dentsply Sirona

    A manufacturer of dental equipment and consumables.

Related articles

$ALGNMedAI 9/10

Align Technology (ALGN) Q2 2026 Earnings Call Transcript

Align Technology (ALGN) reported Q2 2026 revenue of $1,056.2 million, up 4.3% y/y, driven by record Clear Aligner volumes and higher ASPs. Clear Aligner revenue rose 8.2% to $870.9 million on 691,785 cases. Systems and Services revenue fell 10.8% to $185.3 million. Q3 revenue guidance is $1.00 to $1.02 billion; full-year growth 3% to 4%.

$HSICMed

Henry Schein Recasts Its Future Around AI, Simpler Leadership and Faster Execution

Henry Schein Inc. outlined a transformation focused on AI, simpler leadership, and faster execution in its first earnings report under CEO Fred Lowery. The company reported Q2 net sales of $3.46B (+6.7%) and net income of $94M (+9.3%), raised its 2026 sales outlook to 4.5% to 5.5%, and announced a leadership reorganization integrating supply chain and distribution. It targets $200M+ operating improvements.

$HSICMedAI 8/10

Henry Schein, Inc. Q2 2026 Earnings Call Summary

Henry Schein reported Q2 2026 progress including faster internal local-currency sales growth, driven by dental merchandise market-share gains and higher technology platform share. The company raised full-year 2026 sales growth guidance to 4.5% to 5.5% and expects $125 million operating income improvement run rate by end-2026. Restructuring expenses were $29 million.

$NVSTHigh

Envista Holdings Corp (NVST): Results of Operations and Financial Condition

Envista Holdings Corp (NVST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 nvst-ex991x7326xworkingfil.htm EX-99.1 Document Exhibit 99.1 Envista Reports Second Quarter 2026 Results BREA, Calif., August 5, 2026 / PRNewswire / -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended July 3, 2026. “We built on our

$HSICMedAI 8/10

Henry Schein (NASDAQ:HSIC) Surprises With Q2 CY2026 Sales

Henry Schein (NASDAQ:HSIC) reported Q2 CY2026 results with revenue up 6.7% year on year to $3.46 billion, exceeding Wall Street estimates by 2.6%, according to the company. Non-GAAP adjusted EPS was $1.27, up from $1.10, beating consensus by 2.5%. Adjusted operating margin was 5.3%. Analysts expect revenue growth of 2.9% over the next 12 months.